Bone scintigraphy of drug-induced rhabdomyolysis: antihyperlipidemia agent.
Takayama
T
T
Department of Nuclear Medicine, School of Medicine, Kanazawa University, Japan. teruhiko@kenroku.ipc.kanazawa-u.ac.jp
Tsuji
S
S
Taki
J
J
Michigishi
T
T
Tonami
N
N
D001629:Bezafibrate / Q000009:adverse effects*; D001842:Bone and Bones / Q000000981:diagnostic imaging*; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000000981:diagnostic imaging / Q000187:drug effects; D011877:Radionuclide Imaging; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000000981:diagnostic imaging
D000960:Hypolipidemic Agents; D001629:Bezafibrate